SCENTinel provides assurance. When “Vaccination And…” is the strategy for workplace and venue safety, SCENTinel can provide another layer of assurance. SCENTinel offers an efficient and affordable way to screen large groups for probable Covid-19 infection. SCENTinel is the patent-pending, quick, self-administered, objective screen for change in sense of smell.
If you have lost your sense of smell or if it is not functioning properly, please consult a healthcare provider.
For additional support visit the Smell and Taste Association of North America (STANA), the first patient advocacy organization focused on smell and taste disorders in the USA, at www.thestana.org.
SCENTinel was developed by a team of scientists to assess if someone has lost or diminished sense of smell. The SCENTinel device is not intended to provide a diagnosis of COVID-19, however loss of sense of smell is a commonly reported COVID-19 symptom. SCENTinel is a Class II exempt medical device. SCENTinel tests for smell loss/change from Covid-19 – it is a symptom check not a Covid-19 diagnostic. Not having a loss of sense in smell does not indicate a lack of COVID-19.
Seek medical attention if the test detects a loss of ability to smell properly. A complete loss of smell, partial loss of smell, or smelling something different than what is presented indicates that you should consult with a healthcare professional.
The SCENTinel device only tests your sense of smell and it is not intended to diagnose, treat, cure, or prevent any disease.
A normal test result does not rule out diseases or other conditions. Consult a healthcare professional, if you have symptoms of concern.